#USA #Plymouth Meeting #NCCN #Cancer Care #Dr Renuka Iyer

Dr. Renuka Iyer's Appointment as CMO of NCCN

The National Comprehensive Cancer Network (NCCN), an esteemed organization that focuses on promoting high-quality cancer care, has recently announced the appointment of Dr. Renuka Iyer as its new Chief Medical Officer (CMO). Known for her significant contributions to oncology, Dr. Iyer will bring her extensive experience to oversee and innovate cancer treatment guidelines at a time when advancements in the field are rapidly evolving.

Dr. Iyer has built a remarkable career in oncology, currently serving as a professor at Roswell Park Comprehensive Cancer Center, one of the member institutions of NCCN. In her role, she manages the gastroenterology oncology division and the medical oncology department, showcasing her commitment to enhancing patient care through innovative practices. She is also associated with the Jacobs School of Medicine at the University of Buffalo as a professor of medicine.

Her journey in healthcare began in India at Grant Medical College, followed by a clinical oncology fellowship at Roswell Park, where she honed her skills and expertise. After completing her residency at Cornell University College of Medicine, Dr. Iyer became board-certified in internal medicine and oncology. Her accolades include numerous awards and published works in professional journals, outlining her significant contributions to the field. She has a specific focus on rare cancers, immunotherapy, and life quality metrics, reflecting her dedication to patient-centric care.

Dr. Crystal S. Denlinger, the CEO of NCCN, expressed confidence in Dr. Iyer's leadership abilities, stating, “Renuka is the perfect person to take on such an important role that impacts treatment and outcomes for cancer patients worldwide.” The responsibilities of the CMO role include guiding the NCCN Guidelines, overseeing the continuous medical education department, and active engagement in global health initiatives, which are crucial for advancing cancer care practices.

Dr. Iyer will also oversee the NCCN Compendia Library, providing resources based on the established guidelines, ensuring that practitioners have access to the most up-to-date information for patient care. As the NCCN Guidelines Navigator™ tool evolves, her influence will help shape how information is disseminated to healthcare providers and patients, making quality care more accessible.

Excited about her new role starting February 26, 2026, Dr. Iyer remarked, “I am honored to have been selected for this prestigious position and look forward to working at NCCN during this time filled with updates and opportunities for innovation.” Her vision to improve oncology care aligns with NCCN's long-standing mission to define and enhance standards of quality, effectiveness, and access to cancer care globally.

NCCN, now in its 30th year, continually seeks to refine clinical practice guidelines, providing transparent and evidence-based recommendations that have become recognized standards in cancer treatment. By having a leader like Dr. Iyer at the helm, NCCN is poised to further its impact on oncology practices, shaping a future where all cancer patients have equitable access to quality healthcare.

In its commitment to patient education, NCCN also supports initiatives that inform patients about their treatment options, empowering them in their healthcare journey. Dr. Iyer's extensive experience and commitment to oncology will be instrumental in influencing policy and education regarding cancer care.

As NCCN embarks on its next chapter under Dr. Iyer's guidance, it is evident that the organization remains dedicated to advancing the field of oncology, striving for a future where improved health outcomes for cancer patients can be achieved through exemplary standards of care and innovative practices.